In this regard, the in vivo assessment of endothelial
responsiveness by measuring the brachial artery hyperemic
flow-mediated dilatation (FMD) is now viewed as a useful
research tool for assessing cardiovascular evolution in patients
with various degrees of cardiovascular risk.